-
公开(公告)号:US20090155257A1
公开(公告)日:2009-06-18
申请号:US12256349
申请日:2008-10-22
申请人: CAMELLIA W. ADAMS , ANDREW C. CHAN , CRAIG W. CROWLEY , HENRY B. LOWMAN , GERALD R. NAKAMURA , LEONARD G. PRESTA
发明人: CAMELLIA W. ADAMS , ANDREW C. CHAN , CRAIG W. CROWLEY , HENRY B. LOWMAN , GERALD R. NAKAMURA , LEONARD G. PRESTA
CPC分类号: C07K16/2887 , A61K2039/505 , C07K2317/24 , C07K2317/41 , C07K2317/52 , C07K2317/522 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/72 , C07K2317/73 , C07K2317/732 , C07K2317/734 , C07K2317/75 , C07K2317/92
摘要: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
摘要翻译: 本发明提供用于治疗CD20阳性恶性肿瘤和自身免疫疾病的人源化和嵌合抗CD20抗体。
-
公开(公告)号:US20110081342A1
公开(公告)日:2011-04-07
申请号:US12962514
申请日:2010-12-07
CPC分类号: C07K16/22 , C07K2317/24 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells in vitro; and inhibit tumor growth in vivo.
-
公开(公告)号:US20140141011A1
公开(公告)日:2014-05-22
申请号:US14048636
申请日:2013-10-08
IPC分类号: C07K16/24
CPC分类号: C07K16/24 , A61K2039/505 , C07K16/244 , C07K2317/24 , C07K2317/52 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: The invention relates to binding compounds that specifically bind to human TSLP, as well as uses thereof, e.g., in the treatment of inflammatory disorders.
摘要翻译: 本发明涉及特异性结合人TSLP的结合化合物,以及其用途,例如用于治疗炎症性疾病。
-
公开(公告)号:US20100254986A1
公开(公告)日:2010-10-07
申请号:US12700618
申请日:2010-02-04
IPC分类号: A61K39/395 , C12P21/06 , C07K16/00 , C12N5/10
CPC分类号: C07K16/468 , A61K38/00 , C07K14/70514 , C07K16/2809 , C07K16/46 , C07K19/00 , C07K2317/526 , C07K2319/00 , C07K2319/30
摘要: The invention relates to a method of preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras. The invention also relates to the heteromultimers prepared using the method. Generally, the method involves introducing a protuberance at the interface of a first polypeptide and a corresponding cavity in the interface of a second polypeptide, such that the protuberance can be positioned in the cavity so as to promote heteromultimer formation and hinder homomultimer formation. “Protuberances” are constructed by replacing small amino acid side chains from the interface of the first polypeptide with larger side chains (e.g. tyrosine or tryptophan). Compensatory “cavities” of identical or similar size to the protuberances are created in the interface of the second polypeptide by replacing large amino acid side chains with smaller ones (e.g. alanine or threonine). The protuberance and cavity can be made by synthetic means such as altering the nucleic acid encoding the polypeptides or by peptide synthesis.
摘要翻译: 本发明涉及制备异源多聚体多肽如双特异性抗体,双特异性免疫粘附素和抗体免疫粘附素嵌合体的方法。 本发明还涉及使用该方法制备的异源多聚体。 通常,该方法包括在第二多肽的界面中的第一多肽和相应空腔的界面处引入突起,使得突起可以位于空腔中,以促进异源多聚体形成并阻止同源多聚体形成。 通过用较大侧链(例如酪氨酸或色氨酸)从第一多肽的界面替代小的氨基酸侧链构建“突起”。 通过用较小的(例如丙氨酸或苏氨酸)代替大的氨基酸侧链,在第二多肽的界面中产生与突起相同或相似大小的补偿性“空腔”。 突起和空腔可以通过合成方式制备,例如改变编码多肽的核酸或通过肽合成。
-
公开(公告)号:US20130004508A1
公开(公告)日:2013-01-03
申请号:US13532131
申请日:2012-06-25
IPC分类号: A61K39/395 , C12N15/13 , C12N15/63 , C12N1/19 , A61P29/00 , A61P37/08 , A61P11/06 , C12N5/10 , C07K16/24 , C07K16/46
CPC分类号: C07K16/24 , A61K2039/505 , C07K16/244 , C07K2317/24 , C07K2317/52 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: The invention relates to binding compounds that specifically bind to human TSLP, as well as uses thereof, e.g., in the treatment of inflammatory disorders.
摘要翻译: 本发明涉及特异性结合人TSLP的结合化合物,以及其用途,例如用于治疗炎症性疾病。
-
公开(公告)号:US20130004503A1
公开(公告)日:2013-01-03
申请号:US13532139
申请日:2012-06-25
IPC分类号: A61K39/395 , A61P37/06
CPC分类号: C07K16/24 , A61K2039/505 , C07K16/244 , C07K2317/24 , C07K2317/52 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: The invention relates to binding compounds that specifically bind to human TSLP, as well as uses thereof, e.g., in the treatment of inflammatory disorders.
-
公开(公告)号:US20110052596A1
公开(公告)日:2011-03-03
申请号:US12913457
申请日:2010-10-27
IPC分类号: A61K39/395 , C07H21/00 , C07H21/04 , C12N15/63 , C12N5/10 , C12P21/02 , C07K16/24 , A61P29/00 , A61P19/02 , A61P37/06
CPC分类号: C07K16/244 , A61K2039/505 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92
摘要: Engineered antibodies to human IL-17A are provided, as well as uses thereof.
摘要翻译: 提供了人IL-17A的工程抗体及其用途。
-
公开(公告)号:US20100184656A1
公开(公告)日:2010-07-22
申请号:US12401483
申请日:2009-03-10
申请人: ROMAN URFER , LEONARD G. PRESTA , JOHN W. WINSLOW
发明人: ROMAN URFER , LEONARD G. PRESTA , JOHN W. WINSLOW
IPC分类号: A61K38/18 , C07K14/475 , C12N15/12 , C12N15/63 , C12N1/21 , C12N1/15 , C12N1/19 , C12N5/10 , C12P21/00
CPC分类号: A61K38/185 , C07K14/475 , C07K14/48 , C12N15/11
摘要: Pantropic neurotrophic factors which have multiple neurotrophic specificities are provided. The pantropic neurotrophic factors of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the pantropic neurotrophins are also provided.
摘要翻译: 提供了具有多种神经营养特异性的泛性神经营养因子。 本发明的泛素神经营养因子可用于治疗神经元疾病。 还提供了编码泛素神经营养因子的核酸和表达载体。
-
公开(公告)号:US20110038878A1
公开(公告)日:2011-02-17
申请号:US12913471
申请日:2010-10-27
IPC分类号: A61K39/395 , C07K16/24 , A61P29/00 , A61P37/06
CPC分类号: C07K16/244 , A61K2039/505 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92
摘要: Engineered antibodies to human IL-17A are provided, as well as uses thereof.
-
-
-
-
-
-
-
-